Authors:
Yamanaka, R
Zullo, SA
Ramsey, J
Onodera, M
Tanaka, R
Blaese, M
Xanthopoulos, KG
Citation: R. Yamanaka et al., Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus, CANC GENE T, 8(10), 2001, pp. 796-802
Authors:
Ohnuma, H
Tanaka, T
Yoshikawa, A
Murokawa, H
Minegishi, K
Yamanaka, R
Iizuka, HY
Miyamoto, M
Satoh, S
Nakahira, S
Tomono, T
Murozuka, T
Takeda, Y
Doi, Y
Mine, H
Yokoyama, S
Hirose, T
Nishioka, K
Citation: H. Ohnuma et al., The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV, MICROB IMMU, 45(9), 2001, pp. 667-672
Authors:
Yamanaka, R
Zullo, SA
Tanaka, R
Blaese, M
Xanthopoulos, KG
Citation: R. Yamanaka et al., Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA, J NEUROSURG, 94(3), 2001, pp. 474-481
Authors:
Ogata, N
Otsuji, T
Matsushima, M
Kimoto, T
Yamanaka, R
Takahashi, K
Wada, M
Uyama, M
Kaneda, Y
Citation: N. Ogata et al., Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system, CURR EYE R, 18(4), 1999, pp. 261-269
Authors:
Yamanaka, R
Tanaka, R
Yoshida, S
Saitoh, T
Fujita, K
Naganuma, H
Citation: R. Yamanaka et al., Suppression of TGF-beta 1 in human gliomas by retroviral gene transfectionenhances susceptibility to LAK cells, J NEURO-ONC, 43(1), 1999, pp. 27-34
Authors:
Murozuka, T
Aoki, M
Kimura, N
Sotoyama, K
Abe, I
Izumi, H
Emura, H
Takeda, Y
Nanakawa, H
Katsubayashi, Y
Takeuchi, T
Ito, H
Hirakawa, S
Mitsunaga, S
Tadokoro, K
Kanemitsu, K
Miyamoto, M
Yamanaka, R
Nishioka, K
Citation: T. Murozuka et al., Removal and inactivation of hepatitis B virus from contaminated pooled plasma in a large-scale manufacturing process for factor VIII and human serum albumin, VOX SANGUIN, 76(3), 1999, pp. 181-186